The daily business briefing: November 5, 2020
Stocks surge as mixed vote signals more Washington gridlock, AstraZeneca provides update on vaccine timeline, and more
- 1. Markets surge as investors predict Washington gridlock
- 2. AstraZeneca says late-trial vaccine data due by late 2020
- 3. Facebook, Twitter flag Trump election posts as misleading
- 4. Italy, England impose new lockdowns as pandemic surges in Europe
- 5. Nintendo 1st-half profit triples as Switch sales surge
1. Markets surge as investors predict Washington gridlock
U.S. stocks soared on Wednesday as investors apparently expected Tuesday's mixed elections to result in the kind of gridlock in Washington that often lifts markets by making major policy changes impossible. The presidential election remained too close to call, but Democrats appeared to have retained control of the House with Republicans nearly certain to hold onto a narrow Senate majority. The Dow Jones Industrial Average rose by 368 points or 1.3 percent, down from a session-high gain of more than 800 points. The S&P 500 and the Nasdaq closed up by 2.2 percent and 3.9 percent, respectively. The S&P 500 has now risen three straight days, and won back all of its 5.6 percent loss last week. Futures rose further early Thursday.
2. AstraZeneca says late-trial vaccine data due by late 2020
AstraZeneca said Thursday that it expected to release late-stage trial results for its COVID-19 vaccine candidate, which it is developing with the University of Oxford, "later this year." Positive results could lead to a rollout of the vaccine soon after the release of the data, as long as regulators sign off on the vaccine. AstraZeneca's vaccine, called AZD1222, is considered a frontrunner in the race to produce the first drug to help prevent coronavirus infections. European regulators last month made the AstraZeneca-Oxford vaccine candidate the first to begin a fast-tracked review process. The move came after weeks of uncertainty over a pause in trials in the U.S. due to a participant's unexplained illness. The trials resumed after the Food and Drug Administration found no evidence the vaccine caused the illness.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Facebook, Twitter flag Trump election posts as misleading
Facebook and Twitter on Wednesday flagged posts by President Trump as potentially misleading after he prematurely claimed to have won Tuesday's election. Trump also baselessly claimed there had been fraud benefiting Democrats. Facebook labeled posts with a video of Trump's post-election comments with a warning saying that no winner had been determined, adding: "Final results may be different from initial vote counts, as ballot counting will continue for days or weeks. Source: Bipartisan Policy Center." Facebook also displayed a post in its news feed saying, "The winner of the 2020 U.S. President Election has not been projected yet." Twitter flagged a Trump tweet on election results with a warning that "some or all of the content shared in this tweet is disputed and might be misleading about an election or other civic process," and it posted the same warning on a Trump tweet accusing Democrats of trying to "steal" the election.
4. Italy, England impose new lockdowns as pandemic surges in Europe
Italy joined England in imposing new lockdowns to fight new waves of coronavirus infections. Italian Prime Minister Giuseppe Conte announced the country's most drastic measures since a national lockdown in March. Starting Friday, the new restrictions will affect much of Italy, including northern regions that are main drivers of the country's economy. "The situation is particularly critical," Conte said at a news conference. England will impose its second lockdown starting Thursday. The two nations are among several using new restrictions to curb surging infections across Europe. Poland is shutting schools and stores, Lithuania is imposing a full lockdown, and France is extending a state of emergency until February.
5. Nintendo 1st-half profit triples as Switch sales surge
Japanese videogame maker Nintendo said Thursday that its profit more than tripled in the first half of the year as sales surged during the coronavirus pandemic. The company said net profit narrowly surpassed $2 billion. With customers around the world forced to spend more time at home to avoid the risk of infection, Nintendo sold 6.9 million Switch consoles during the last quarter, up from 4.8 million sold in the same period last year. The surge lifted lifetime Switch sales to 68.3 million. The console is now closing in on Nintendo's 3DS and 2DS family, which have 75.9 million lifetime sales.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
8 genre-defining Black country, folk and blues musicians
The Week Recommends Keeping the legacy alive, even when the industry tries to keep them down
By Scott Hocker, The Week US Published
-
Will young people refuse to vote in the 2024 presidential election?
Today's Big Question The kids are not alright
By Anya Jaremko-Greenwold, The Week US Published
-
What reclassifying cannabis could change
The Explainer The Biden administration's move to change marijuana from a Schedule I narcotic to Schedule III could reshape the pot landscape even if it doesn't mean full federal legalization
By Rafi Schwartz, The Week US Published
-
The daily business briefing: January 24, 2024
Business Briefing The S&P 500 sets a third straight record, Netflix adds more subscribers than expected, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 23, 2024
Business Briefing The Dow and S&P 500 set fresh records, Bitcoin falls as ETF enthusiasm fades, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 22, 2024
Business Briefing FAA recommends inspections of a second Boeing 737 model, Macy's rejects Arkhouse bid, and more
By Harold Maass, The Week US Published
-
Geopolitics and the economy in 2024
Talking Point The West is banking on a year of falling inflation. Don't rule out a shock
By The Week UK Published
-
The daily business briefing: January 19, 2024
Business Briefing Macy's to cut 2,350 jobs, Congress averts a government shutdown, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 18, 2024
Business Briefing Shell suspends shipments in the Red Sea, December retail sales beat expectations, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 17, 2024
Business Briefing Judge blocks JetBlue-Spirit merger plan, Goldman Sachs beats expectations with wealth-management boost, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 16, 2024
Business Briefing Boeing steps up inspections on 737 Max 9 jets, Zelenskyy fights for world leaders' attention at Davos, and more
By Harold Maass, The Week US Published